InvestorsHub Logo

rafunrafun

06/12/19 9:24 AM

#196278 RE: MedResCollab #196276

Would it bother you to spend 0.06% of a position on an extensive report about that position?


If the author's name & credentials were available and the product seemed legit, then maybe. Clearly this isn't the case here. Don't believe me? Check your total sales. Oops.

Another failed project?

hayward

06/12/19 9:41 AM

#196282 RE: MedResCollab #196276

ANYONE THAT HAS 50 MILLION DOLLARS INVESTED IN AMARIN DOES NOT NEED YOUR ADVICE

Michael